Active	Status	Sponsor type	Region	Phase	Filter
3 Active 14 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ROUSSEL, Murielle
NCT06649695: A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis	Not yet recruiting	2	30	Europe, RoW	Teclistamab, JNJ-64007957	European Myeloma Network B.V., Janssen Research & Development	AL Amyloidosis	09/28	09/28
Attal, Michel
IFM2018-01, NCT03669445: Study Association of Lenalidomide, Ixazomib, Dexamethasone and Daratumumab in Newly Diagnosed Standard Risk Multiple Myeloma	Recruiting	2	45	Europe	Ixazomib, Lenalidomide, Dexamethasone, Daratumumab	University Hospital, Toulouse	Multiple Myeloma	03/24	12/24
PreFamDys, NCT02853214: Familial Dysglobulinemia	Completed	N/A	1868	Europe	Genetic analysis of peripheral blood samples	Hospices Civils de Lyon	Dysglobulinemia	09/23	09/23